King K A, Pang C C
Department of Pharmacology and Therapeutics, Faculty of Medicine, University of British Columbia, Vancouver, Canada.
Can J Physiol Pharmacol. 1988 Nov;66(11):1455-60. doi: 10.1139/y88-237.
The effect of intracerebroventricular (i.c.v.) injection of the alpha 2-adrenoceptor agonists clonidine and B-HT 920 on mean arterial pressure (MAP), heart rate (HR), and plasma concentrations of noradrenaline and adrenaline was examined in conscious unrestrained rats. The injection of 1.0 microgram clonidine significantly decreased MAP and slightly decreased HR. Plasma noradrenaline and adrenaline levels were slightly but not significantly decreased after the injection of 1 microgram clonidine. In contrast, the injection of 0.1-10.0 micrograms B-HT 920 increased MAP and decreased HR. Plasma noradrenaline and adrenaline levels were slightly increased after the injection of the 1- and 10-micrograms doses. The i.c.v. injection of the alpha 2-antagonist rauwolscine slightly but not significantly increased MAP and plasma noradrenaline and adrenaline levels. The responses to i.c.v. injection of clonidine and B-HT 920 were not changed by prior administration of rauwolscine. Neither the pressor response to B-HT 920 nor the depressor response to clonidine was abolished by rauwolscine, suggesting that neither response was mediated by alpha 2-adrenoceptors.
在清醒无束缚大鼠中,研究了脑室内(i.c.v.)注射α2 - 肾上腺素能受体激动剂可乐定和B - HT 920对平均动脉压(MAP)、心率(HR)以及去甲肾上腺素和肾上腺素血浆浓度的影响。注射1.0微克可乐定可显著降低MAP,并轻微降低HR。注射1微克可乐定后,血浆去甲肾上腺素和肾上腺素水平略有下降,但无显著差异。相比之下,注射0.1 - 10.0微克B - HT 920可升高MAP并降低HR。注射1微克和10微克剂量的B - HT 920后,血浆去甲肾上腺素和肾上腺素水平略有升高。脑室内注射α2 - 拮抗剂萝芙木碱可轻微升高MAP以及血浆去甲肾上腺素和肾上腺素水平,但无显著差异。预先给予萝芙木碱并不改变对脑室内注射可乐定和B - HT 920的反应。萝芙木碱既未消除对B - HT 920的升压反应,也未消除对可乐定的降压反应,这表明两种反应均不是由α2 - 肾上腺素能受体介导的。